Cultural Adaptation, Validity, and Reliability of the Turkish Version of North Star Ambulatory Assessment
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Duchenne Muscular Dystrophy
- Sponsor
- Hacettepe University
- Enrollment
- 86
- Locations
- 1
- Primary Endpoint
- North Star Ambulatory Assessment
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The aim of this study is to translate the "North Star Ambulatory Assessment (NSAA)" scale into Turkish and make its cultural adaptation and to demonstrate the reliability and validity of the Turkish version in patients with ambulatory DMD. For the translation into Turkish, validity and reliability of the NSAA, necessary permission was obtained from the developer of the questionnaire, Prof. Dr. Francesco Muntoni, via e-mail. In the study, first of all, the translation and cultural adaptation process will be completed, and then reliability-validity studies will be carried out.
Investigators
Güllü AYDIN YAĞCIOĞLU
Research Asisstant
Suleyman Demirel University
Eligibility Criteria
Inclusion Criteria
- •Being diagnosed with DMD
- •Ambulatory
- •Being between the ages of 4-18
- •Agreeing to participate in the research voluntarily
Exclusion Criteria
- •Insufficient cooperation with the physiotherapist,
- •Have had any injury and/or surgery of the lower extremities in the last 6 months,
- •Having neurological problems in addition to DMD. -
Outcomes
Primary Outcomes
North Star Ambulatory Assessment
Time Frame: 10 minutes
The North Star Ambulatory Assessment (NSAA) is a functional scale specifically designed for ambulant boys with DMD. The instrument contains clear and detailed instructions, with item scores varying according to a simple three point criteria, which should allow accurate reproduction by different groups. The scale has also the advantage to be quick to perform and to be suitable for application in young children. The NSAA also includes two timed items, run/walk for 10 meters and rise from the floor. While those times do not influence the score, they can be used to monitor changes over time. Although it was developed to assess ambulatory patients, the NSAA has been widely accepted and used to evaluate ambulatory motor performance in children and young adults with DMD, as well as in patients with other neuromuscular diseases.
Secondary Outcomes
- 6 meter walking test (6MWT)(6 minutes)
- Motor Function Measure (MFM)(20-30 minutes)